NWBO
Northwest Biotherapeutics, Inc. Common stock
NWBO
NWBO
Delisted
NWBO was delisted on the 16th of December, 2016.
44 hedge funds and large institutions have $23.5M invested in Northwest Biotherapeutics, Inc. Common stock in 2013 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 13 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
82% less call options, than puts
Call options by funds: $180K | Put options by funds: $1.02M
Holders
44
Holding in Top 10
–
Calls
$180K
Puts
$1.02M
Top Buyers
| 1 | +$2.34M | |
| 2 | +$1.28M | |
| 3 | +$1.01M | |
| 4 |
BFIC
Bedell Frazier Investment Counselling
Walnut Creek,
California
|
+$428K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$415K |
Top Sellers
| 1 | -$3.28M | |
| 2 | -$111K | |
| 3 | -$37.5K | |
| 4 |
Barclays
London,
United Kingdom
|
-$7K |
| 5 |
KA
Kovack Advisors
Ft. Lauderdale,
Florida
|
-$2.77K |